Richard Zelman MD | Current Advances and Clinical Trials

The field of cardiac cell therapy is rapidly evolving, with several ongoing clinical trials assessing the safety and efficacy of various cell-based approaches. Dr. Zelman points to some of the most promising studies:

The C-CURE Trial: This trial investigated the use of cardiac progenitor cells in patients with chronic heart failure. Results showed that patients who received cell therapy experienced significant improvements in heart function and exercise capacity compared to those who received standard care.